- Board member since: 2021
- Independent in relation to the Company and its management: Yes
- Independent in relation to major shareholders: Yes
- Holdings in Alligator: 101,550 shares, 100,000 warrants in program TO 2022/2025 II and 240,000 warrants in program TO 2023/2026 II.
- Other current positions: Board member for a number of subsidiaries within the Episurf Group, Board member in IRLAB Therapeutics AB, Board member in Integrative Research Laboratories Sweden AB.
Veronica Wallin – born 1986, Board member since 2021 – has a Master of Science in Business and Economics from Stockholm University. Veronica Wallin is the CFO at the medical technology company Episurf Medical AB since 2017. Veronica Wallin has previously, among other things, been CFO at the pharmacy company ApoEx AB.